Molecular Point-of-care testing Market - Forecast(2024 - 2030)

Report Code: HCR 1492 Report Format: PDF + Excel
1. Global Molecular POCT Market- Market Overview
    1.1 Definitions and Scope
2. Global Molecular POCT Market - Executive Summary
    2.1 Market Revenue, Market Size and Key Trends by Company
    2.2 Key trends by Application
    2.3 Key trends by Geography
3. Global Molecular POCT Market – Landscape
    3.1 Market Share Analysis- Top Companies
    3.2 Product Benchmarking- Top Companies
    3.3 Top 5 Financials Analysis
    3.4 Patent Analysis- Top Companies
    3.5 Pricing Analysis
        3.5.1 By Test and By Player
        3.5.2 By POCT Instruments and By Player
4. Global Molecular POCT Market - Startup companies Scenario Premium Premium
    4.1 Top startup company Analysis by
        4.1.1 Investment
        4.1.2 Revenue
        4.1.3 Application Analysis
        4.1.4 Venture Capital and Funding Scenario
5. Global Molecular POCT Market – Industry Market Entry Scenario Premium Premium
    5.1 Regulatory Framework Overview
    5.2 New Business and Ease of Doing business index
    5.3 Successful venture profiles
    5.4 Customer Analysis – Top companies
6. Global Molecular POCT Market - Market Forces
    6.1 Market Drivers
    6.2 Market Constraints
    6.3 Market Opportunities
    6.4 Porters five force model
        6.4.1 Bargaining power of suppliers
        6.4.2 Bargaining powers of customers
        6.4.3 Threat of new entrants
        6.4.4 Rivalry among existing players
        6.4.5 Threat of substitutes
7. Global Molecular POCT Market – Strategic Analysis
    7.1 Value Chain Analysis
    7.2 Opportunity Analysis
    7.3 Product Life Cycle
    7.4 Supplier and Distributor
8. Global Molecular POCT Market- By Product and Services (Market Size-$M)
    8.1 Assays & Kits
    8.2 Instruments/Analyzers
    8.3 Software & Services
9. Global Molecular POCT Market- By Indications (Market Size-$M)
    9.1 Respiratory
        9.1.1 Covid-19
        9.1.2 Flu A
        9.1.3 Flu B
        9.1.4 RSV
    9.2 STI
        9.2.1 CT
        9.2.2 NG
        9.2.3 UU
        9.2.4 MG
        9.2.5 MH
        9.2.6 Others
    9.3 HPV
    9.4 Gastrointestinal Tract
        9.4.1 Shiga Toxin
        9.4.2 H.Pylori
        9.4.3 Group B Streptococcus
    9.5 Tuberculosis
    9.6 Pneumonia
    9.7 Others
10. Global Molecular POCT Market – By End Use (Market Size -$Million)
    10.1 Physician Offices
    10.2 Hospital Emergency & ICUs
    10.3 Research Institutes
    10.4 Others
11. Global Molecular POCT Market - By Geography (Market Size -$Million)
    11.1 Key Players Annual Test Volumes – By Country
    11.2 Number of POCT Instruments Installed – By Country
    11.3 North America
        11.3.1 U.S
        11.3.2 Canada
    11.4 Europe
        11.4.1 UK
        11.4.2 Germany
        11.4.3 France
        11.4.4 Italy
        11.4.5 Spain
        11.4.6 Rest of Europe
    11.5 Middle East
        11.5.1 Saudi Arabia
        11.5.2 UAE
        11.5.3 Israel
        11.5.4 Rest of Middle East
    11.6 Africa
        11.6.1 South Africa
        11.6.2 Kenya
        11.6.3 Nigeria
        11.6.4 Rest of Africa
    11.7 South East Asia
        11.7.1 Singapore
        11.7.2 Malaysia
        11.7.3 Philippines
        11.7.4 Vietnam
        11.7.5 Thailand
        11.7.6 Rest of SEA
    11.8 South Asia
        11.8.1 India
        11.8.2 Bangladesh
        11.8.3 Pakistan
        11.8.4 Rest of South Asia
12. Global Molecular POCT Market – Entropy
    12.1 New Product Launches
    12.2 M&As, Collaborations, JVs and Partnerships
13. Global Molecular POCT Market Company Analysis (Company Revenue, Products, M&A, Developments)
    13.1 Lucira
    13.2 Mesa BioTech
    13.3 BinX
    13.4 Abbott
    13.5 Cepheid
    13.6 Genepoc
    13.7 Mobidiaq
    13.8 Q-POC
    13.9 Company 9
    13.10 Company 10 and more
"*Financials would be provided on a best efforts basis for private companies*"